Join the Apremilast group to help and get support from people like you.
Apremilast News
FDA Approves Otezla (apremilast) for the Treatment of Adult Patients with Plaque Psoriasis, Regardless of Severity Level
THOUSAND OAKS, Calif., Dec. 20, 2021 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla® (apremilast) for the treatment of adult ...
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 – Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) 30 mg twice daily (BID) for the...
FDA Approves Otezla (apremilast) for Moderate to Severe Plaque Psoriasis
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast), the Company's oral, selective inhibitor of...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Psoriatic Arthritis, Plaque Psoriasis, Psoriasis